These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36524089)

  • 1. Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB-IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial.
    Lin J; Yang T; Chen W; Qi X; Cao Y; Zheng X; Chen H; Sun L; Lin L
    J Thorac Dis; 2022 Nov; 14(11):4560-4570. PubMed ID: 36524089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zhengyuan capsule for the treatment of cancer-related fatigue in lung cancer patients undergoing operation: a study protocol for a randomized controlled trial.
    Zhang ZJ; Zhang M; Wu XT; Cui Q; Guo YJ
    J Tradit Chin Med; 2021 Jun; 41(3):486-491. PubMed ID: 34114408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenmai injection for the treatment of cancer-related fatigue in advanced non-small cell lung cancer patients undergoing chemotherapy: study protocol for a randomized controlled trial.
    Zhou Y; Zhao B; Wu W; Yang X; Long S; Deng H; He W; Liao G; Li Q; Xie Z
    Trials; 2018 Sep; 19(1):474. PubMed ID: 30180874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
    Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
    Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot Study.
    Chen W; Lin J; Yang T; Xin Zhang Z; Tao L; Xiao Z; Chen H; Qi X; Sun L; Cao Y; Lin L
    Integr Cancer Ther; 2023; 22():15347354221151147. PubMed ID: 36710490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of Kyung-Ok-Ko on cancer-related fatigue in lung cancer patients: Study protocol for a randomized, patients-assessor blind, placebo-controlled, parallel-group, single-center trial.
    Kim KI; Kong M; Lee SH; Lee BJ
    Medicine (Baltimore); 2019 Nov; 98(44):e17717. PubMed ID: 31689808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Safety, Effectiveness, and Cost-Effectiveness of a Chinese Patent Medicine (Fufang E'jiao Syrup) for Alleviating Cancer-Related Fatigue: A Protocol for a Randomized, Double-Blinded, Placebo-Controlled, Multicenter Trial.
    Song Z; Sun LY; Gu SS; Zhu XS; Lai HZ; Lu F; Cui N; Li QY; Wu Y; Xu Y
    Integr Cancer Ther; 2021; 20():15347354211002919. PubMed ID: 33834863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Mild Moxibustion on Cancer-Related Fatigue in Non-Small-Cell Lung Cancer Patients Undergoing Chemotherapy.
    Xu X; Gu F
    Comput Math Methods Med; 2022; 2022():6530454. PubMed ID: 35912144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial.
    Xiao Z; Chen Z; Han R; Lu L; Li Z; Lin J; Hu L; Huang X; Lin L
    Medicine (Baltimore); 2021 May; 100(18):e25690. PubMed ID: 33950949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of an amino acid jelly containing coenzyme Q10 and L-carnitine in controlling fatigue in breast cancer patients receiving chemotherapy: a multi-institutional, randomized, exploratory trial (JORTC-CAM01).
    Iwase S; Kawaguchi T; Yotsumoto D; Doi T; Miyara K; Odagiri H; Kitamura K; Ariyoshi K; Miyaji T; Ishiki H; Inoue K; Tsutsumi C; Sagara Y; Yamaguchi T
    Support Care Cancer; 2016 Feb; 24(2):637-646. PubMed ID: 26105516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial.
    Ji Y; Li S; Zhang X; Liu Y; Lu Q; Li Q; Chen W; Sheng J; Jiang K; Liang H; Sha S; Li M; Chen Z; Zheng P; Wang M; Feng Y; Wang L; Wu H; Liu H; Huang Y; Yin Z; Xue X
    Trials; 2020 Oct; 21(1):844. PubMed ID: 33046128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in conjunction with traditional Chinese medicine for survival of elderly patients with advanced non-small-cell lung cancer: protocol for a randomized double-blind controlled trial.
    Zhou ZY; Xu L; Li HG; Tian JH; Jiao LJ; You SF; Han ZF; Jiang Y; Guo HR; Liu H
    J Integr Med; 2014 May; 12(3):175-81. PubMed ID: 24861837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of traditional Chinese medicine, Shen-Mai San, in cancer patients undergoing chemotherapy or radiotherapy: study protocol for a randomized, double-blind, placebo-controlled trial.
    Lo LC; Chen CY; Chen ST; Chen HC; Lee TC; Chang CS
    Trials; 2012 Dec; 13():232. PubMed ID: 23206440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
    Yao J; Jiao L; Yao Y; Lu Y; Shi J; Li J; Chen P; Xu L; Gong Y
    Trials; 2020 Apr; 21(1):309. PubMed ID: 32245480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Outcomes of Postoperative NSCLC Patients with or without Staged Chinese Herb Medicine Therapy during Adjuvant Chemotherapy (NALLC 2): A Randomized, Double-Blind, Placebo-Controlled Trial.
    Zhang YL; Jiao LJ; Gong YB; Xu JF; Ni J; Shen XY; Zhang J; Zhou D; Qian CX; Wang Q; Yao JL; Yang WX; Su LZ; Wang LY; Li JQ; Yao YQ; Zhang YH; Wang YC; Chen ZW; Xu L
    Chin J Integr Med; 2024 Nov; 30(11):963-973. PubMed ID: 39266862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study protocol for HEalth-Related quality of life-intervention in survivors of Breast and other cancers experiencing cancer-related fatigue using TraditionAL Chinese Medicine: the HERBAL trial.
    Yap NY; Loo WS; Zheng HF; Tan QM; Tan TK; Quek LYP; Tan CJ; Toh YL; Ng CC; Ang SK; Tan VKM; Ho HK; Chew L; Loh KW; Tan TJY; Chan A
    Trials; 2020 Nov; 21(1):909. PubMed ID: 33187543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial.
    D'Almeida Preto D; Baston MT; Geraige CC; Augusto SB; de Oliveira MA; Mamere AE; Pinto GDJ; Dias JM; De Marchi PRM; Paiva BSR; Paiva CE
    BMC Cancer; 2019 Apr; 19(1):382. PubMed ID: 31023257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.